Danielle Murphy

1.2k total citations · 1 hit paper
13 papers, 935 citations indexed

About

Danielle Murphy is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Danielle Murphy has authored 13 papers receiving a total of 935 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Cancer Research. Recurrent topics in Danielle Murphy's work include Colorectal Cancer Treatments and Studies (3 papers), Cancer Genomics and Diagnostics (3 papers) and Renal cell carcinoma treatment (2 papers). Danielle Murphy is often cited by papers focused on Colorectal Cancer Treatments and Studies (3 papers), Cancer Genomics and Diagnostics (3 papers) and Renal cell carcinoma treatment (2 papers). Danielle Murphy collaborates with scholars based in United States, France and Spain. Danielle Murphy's co-authors include Jeff H. Tsai, Jing Yang, Joana Liu Donaher, Josep Tabernero, Adrian Edwards, Eric Van Cutsem, Elena Élez, Katia Dotti, Filippo de Braud and Qiuhong Zhao and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Cell and Cancer Research.

In The Last Decade

Danielle Murphy

12 papers receiving 927 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Spatiotemporal Regulation of Epithelial-Mesenchymal Transition Is Essential for Squamous Cell Carcinoma Metastasis

2012 854 citations Jeff H. Tsai, Joana Liu Donaher et al. Cancer Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Danielle Murphy United States	5	641	549	308	132	120	13	935
Julia Mitschke Germany	6	464 0.7×	545 1.0×	351 1.1×	99 0.8×	93 0.8×	7	890
Xiang Hang China	7	397 0.6×	486 0.9×	180 0.6×	70 0.5×	76 0.6×	20	756
Zhaoting Yang China	17	304 0.5×	382 0.7×	182 0.6×	83 0.6×	69 0.6×	26	647
Jeffrey Hung United States	3	804 1.3×	562 1.0×	275 0.9×	92 0.7×	64 0.5×	5	1.1k
Jacqueline E. Noll Australia	15	421 0.7×	549 1.0×	239 0.8×	50 0.4×	81 0.7×	23	923
Helga Lind Nielsen Denmark	4	486 0.8×	390 0.7×	183 0.6×	94 0.7×	74 0.6×	6	699
Jiong Li United States	16	313 0.5×	815 1.5×	250 0.8×	122 0.9×	67 0.6×	32	1.1k
Gonzalo Torga United States	11	229 0.4×	327 0.6×	326 1.1×	157 1.2×	132 1.1×	24	668
Elisa Melucci Italy	18	465 0.7×	421 0.8×	244 0.8×	108 0.8×	44 0.4×	31	871
Maria A. Papadaki Greece	14	854 1.3×	340 0.6×	636 2.1×	228 1.7×	63 0.5×	35	1.1k

Countries citing papers authored by Danielle Murphy

Since Specialization

Citations

This map shows the geographic impact of Danielle Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danielle Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danielle Murphy more than expected).

Fields of papers citing papers by Danielle Murphy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danielle Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danielle Murphy. The network helps show where Danielle Murphy may publish in the future.

Co-authorship network of co-authors of Danielle Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of Danielle Murphy. A scholar is included among the top collaborators of Danielle Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danielle Murphy. Danielle Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Gaude, Edoardo, Danielle Murphy, Jakob V. E. Gerstl, et al.. (2025). Detection of GFAP and D‐Dimer in a Point‐of‐Care Test for Large Vessel Occlusion Ischemic Stroke. Stroke Vascular and Interventional Neurology. 5(2). e001559–e001559. 1 indexed citations

Alsuliman, Tamim, Nour Moukalled, Éolia Brissot, et al.. (2024). Sexual health and emotional wellbeing of patients with haematological malignancies: general review. The Lancet Haematology. 11(10). e770–e779. 3 indexed citations

Shah, Rahul, Danielle Murphy, James H. Jerkins, et al.. (2024). Multidisciplinary Management of Morbidities Associated with Chronic Graft-Versus-Host Disease. PubMed. 6(4). 74–88. 3 indexed citations

Tabernero, Josep, Eric Van Cutsem, Elena Garralda, et al.. (2023). A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAFV600E-MutantKRASWild-Type Metastatic Colorectal Cancer. The Oncologist. 28(3). 230–238. 34 indexed citations

Shiely, Frances, Danielle Murphy, & Seán Millar. (2023). Clinical research nurse predictions of trial failure, recruitment and retention: a case for their early inclusion in trial design. Trials. 24(1). 458–458.

Cutsem, Eric Van, Rona Yaeger, Jean‐Pierre Delord, et al.. (2023). Phase Ib/II Study of the Efficacy and Safety of Binimetinib (MEK162) Plus Panitumumab for Mutant or Wild-Type RAS Metastatic Colorectal Cancer. The Oncologist. 28(12). e1209–e1218. 3 indexed citations

Kopetz, Scott, Takayuki Yoshino, Tae Won Kim, et al.. (2023). BREAKWATER safety lead-in (SLI): Encorafenib (E) + cetuximab (C) + chemotherapy for BRAF^V600E metastatic colorectal cancer (mCRC).. Journal of Clinical Oncology. 41(4_suppl). 119–119. 14 indexed citations

Zhao, Qiuhong, et al.. (2021). Letermovir Prophylaxis and Cytomegalovirus Reactivation in Adult Hematopoietic Cell Transplant Recipients with and without Acute Graft Versus Host Disease. Cancers. 13(21). 5572–5572. 13 indexed citations

Murphy, Danielle, Brian I. Rini, Bernard Escudier, et al.. (2020). Angiogenic and immunomodulatory biomarkers in axitinib-treated patients with advanced renal cell carcinoma. Future Oncology. 16(17). 1199–1210. 5 indexed citations

10.

Brody, Aaron, et al.. (2019). A Novel Silicon Device for the Packing of Cutaneous Abscesses. Journal of Emergency Medicine. 56(3). 298–300. 2 indexed citations

11.

Rini, Brian I., Bernard Escudier, Danielle Murphy, et al.. (2019). Angiogenic and immunomodulatory biomarkers in axitinib-treated patients (pts) with advanced renal cell carcinoma (aRCC).. Journal of Clinical Oncology. 37(7_suppl). 614–614. 1 indexed citations

12.

Fagan, Patrick, Colin Walsh, Danielle Murphy, et al.. (2017). Abstract 5158: Anti-tumor activity of entrectinib, a highly potent pan-TRK, ROS1 and ALK inhibitor, in molecularly defined acute myeloid leukemia. Cancer Research. 77(13_Supplement). 5158–5158. 2 indexed citations

13.

Tsai, Jeff H., et al.. (2012). Spatiotemporal Regulation of Epithelial-Mesenchymal Transition Is Essential for Squamous Cell Carcinoma Metastasis. Cancer Cell. 22(6). 725–736. 854 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact